(HealthDay)—The frequency of long-term symptoms associated with COVID-19 is higher among individuals who self-reported ever receiving a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, according to
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces various health complications all over the body. New research published in the journal Nature found the presence of SARS-CoV-2
A review of nearly 28,000 emergency department records shows less than 2% of patients diagnosed with COVID-19 suffered an ischemic stroke but those who did had an increased
Researchers in the field of mathematics education at the University of Regensburg, together with medical education researchers at the LMU University Hospital of Munich, have found that medical
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROCACTSC20420 pronounced (Act-tem-ra) contains the active ingredient tocilizumab (rch) Consumer Medicine Information What is in
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NUCALA® mepolizumab 100 mg powder for injection Australian Consumer Medicine Information What is in this
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PERGOVERIS® Follitropin alfa (rch)/Lutropin alfa (rch) Solution for Injection Consumer Medicine Information What is in
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
